|
KIAA0232 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.01620000003688E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57213999999462E-05 |
| Normal-vs-Stage2 |
9.459800E-03 |
| Normal-vs-Stage3 |
1.51639000000037E-05 |
| Normal-vs-Stage4 |
9.25279997066042E-09 |
| Stage1-vs-Stage2 |
4.785400E-01 |
| Stage1-vs-Stage3 |
4.905600E-01 |
| Stage1-vs-Stage4 |
8.144800E-03 |
| Stage2-vs-Stage3 |
2.880200E-01 |
| Stage2-vs-Stage4 |
3.086100E-02 |
| Stage3-vs-Stage4 |
9.667800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03620000002635E-06 |
| Normal-vs-AfricanAmerican |
1.358390E-01 |
| Normal-vs-Asian |
1.396380E-04 |
| Caucasian-vs-AfricanAmerican |
1.144250E-01 |
| Caucasian-vs-Asian |
8.844200E-01 |
| AfricanAmerican-vs-Asian |
1.580970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.96669999975275E-07 |
| Normal-vs-Female |
4.70450000000788E-06 |
| Male-vs-Female |
2.472800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.50489999999337E-05 |
| Normal-vs-Age(41-60Yrs) |
4.11000000000161E-05 |
| Normal-vs-Age(61-80Yrs) |
1.74034999999018E-05 |
| Normal-vs-Age(81-100Yrs) |
2.495600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.886200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.082400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.014000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.382400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.258600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.930400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.555600E-04 |
| Classical-VS-Follicular |
1.530200E-02 |
| Classical-VS-Other |
7.687900E-02 |
| Classical-VS-Normal |
2.776300E-04 |
| Tall-VS-Follicular |
2.938600E-01 |
| Tall-VS-Other |
4.811000E-01 |
| Tall-VS-Normal |
4.56480000465831E-08 |
| Follicular-VS-Other |
3.266200E-01 |
| Follicular-VS-Normal |
6.88520000013959E-07 |
| Other-VS-Normal |
1.503910E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64553999999484E-05 |
| Normal-vs-N1 |
1.67509999982052E-07 |
| N0-vs-N1 |
1.346410E-01 |
|
|
